EP0810853B1
(en)
*
|
1995-02-24 |
2004-08-25 |
Elan Pharma International Limited |
Aerosols containing nanoparticle dispersions
|
JP3523821B2
(ja)
*
|
2000-02-09 |
2004-04-26 |
ナノキャリア株式会社 |
薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
|
US6632671B2
(en)
|
2000-02-28 |
2003-10-14 |
Genesegues, Inc. |
Nanoparticle encapsulation system and method
|
US7153525B1
(en)
*
|
2000-03-22 |
2006-12-26 |
The University Of Kentucky Research Foundation |
Microemulsions as precursors to solid nanoparticles
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
WO2003000226A2
(en)
*
|
2001-06-22 |
2003-01-03 |
Pfizer Products Inc. |
Pharmaceutical compositions containing polymer and drug assemblies
|
EP1429749A2
(en)
|
2001-09-26 |
2004-06-23 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
AU2003227147A1
(en)
*
|
2002-04-05 |
2003-10-27 |
Universite De Montreal |
Stealthy polymeric biodegradable nanospheres and uses thereof
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
JP2003342196A
(ja)
*
|
2002-05-31 |
2003-12-03 |
Mukku:Kk |
静脈注射用組成物、その製造法およびその製剤
|
CN1302773C
(zh)
*
|
2002-07-09 |
2007-03-07 |
成都思摩纳米技术有限公司 |
二十二碳六烯酸的纳米悬浮液的制备方法
|
US20060189554A1
(en)
*
|
2002-09-24 |
2006-08-24 |
Russell Mumper |
Nanoparticle-Based vaccine delivery system containing adjuvant
|
CA2500908A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
EP1626742A1
(en)
*
|
2003-05-22 |
2006-02-22 |
Elan Pharma International Limited |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
US8071134B2
(en)
*
|
2003-09-15 |
2011-12-06 |
Ordway Research Institute, Inc. |
Thyroid hormone analogs and methods of use
|
US8668926B1
(en)
|
2003-09-15 |
2014-03-11 |
Shaker A. Mousa |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
EP2335694B1
(en)
*
|
2003-09-15 |
2018-06-13 |
NanoPharmaceuticals LLC |
Thyroid hormone analogs and methods of use
|
US9198887B2
(en)
|
2003-09-15 |
2015-12-01 |
Nanopharmaceuticals Llc |
Thyroid hormone analogs and methods of use
|
WO2005077337A2
(en)
*
|
2004-02-05 |
2005-08-25 |
Baxter International Inc. |
Dispersions prepared by use of self-stabilizing agents
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
WO2006096518A2
(en)
|
2005-03-04 |
2006-09-14 |
Neurosystec Corporation |
Improved gacyclidine formulations
|
US10130686B2
(en)
|
2005-09-15 |
2018-11-20 |
Nanopharmaceuticals Llc |
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
|
US9498536B2
(en)
|
2005-09-15 |
2016-11-22 |
Nanopharmaceuticals Llc |
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
|
WO2007035612A2
(en)
|
2005-09-16 |
2007-03-29 |
Ordway Research Institute, Inc. |
Polyphenol conjugates as rgd-binding compounds and methods of use
|
US9393215B2
(en)
*
|
2005-12-02 |
2016-07-19 |
Novartis Ag |
Nanoparticles for use in immunogenic compositions
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
US7803148B2
(en)
*
|
2006-06-09 |
2010-09-28 |
Neurosystec Corporation |
Flow-induced delivery from a drug mass
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
WO2008002568A2
(en)
*
|
2006-06-26 |
2008-01-03 |
Mutual Pharmaceutical Company, Inc. |
Active agent formulations, methods of making, and methods of use
|
EP2120913B1
(en)
*
|
2006-12-22 |
2015-01-21 |
NanoPharmaceuticals LLC |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
|
US20090074828A1
(en)
|
2007-04-04 |
2009-03-19 |
Massachusetts Institute Of Technology |
Poly(amino acid) targeting moieties
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
US8974827B2
(en)
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
DK2644192T3
(en)
|
2007-09-28 |
2017-06-26 |
Pfizer |
Cancer cell targeting using nanoparticles
|
EP2630967A1
(en)
|
2007-10-12 |
2013-08-28 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
US9233078B2
(en)
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
WO2009073215A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
EP2278999A4
(en)
|
2008-04-21 |
2015-04-22 |
Otonomy Inc |
EARLY TREATMENT FORMULATIONS FOR THE TREATMENT OF EARLY DISEASES AND DRESSES
|
EP2303227B1
(en)
|
2008-05-14 |
2021-10-06 |
Otonomy, Inc. |
Controlled release corticosteroid compositions and methods for the treatment of otic disorders
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
PL2774608T3
(pl)
*
|
2008-06-16 |
2020-05-18 |
Pfizer Inc. |
Polimerowe nanocząstki napełnione lekiem oraz sposoby ich wytwarzania i zastosowania
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
EP2309991B1
(en)
*
|
2008-06-16 |
2019-03-06 |
Pfizer Inc |
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
|
JP5421366B2
(ja)
|
2008-07-21 |
2014-02-19 |
オトノミ―,インク. |
制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
|
US8784870B2
(en)
*
|
2008-07-21 |
2014-07-22 |
Otonomy, Inc. |
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
|
US8318817B2
(en)
|
2008-07-21 |
2012-11-27 |
Otonomy, Inc. |
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8563041B2
(en)
*
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
US20100216804A1
(en)
*
|
2008-12-15 |
2010-08-26 |
Zale Stephen E |
Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
|
US20100159021A1
(en)
*
|
2008-12-23 |
2010-06-24 |
Paul Davis |
Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
US9180107B2
(en)
*
|
2009-03-31 |
2015-11-10 |
Nanopharmaceuticals Llc |
Combination treatment of cancer with cetuximab and tetrac
|
CA2765792C
(en)
*
|
2009-06-17 |
2017-03-28 |
Ordway Research Institute, Inc. |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
|
CN102811743B
(zh)
|
2009-12-11 |
2015-11-25 |
佰恩德治疗股份有限公司 |
冻干治疗颗粒的稳定制剂
|
WO2011084513A2
(en)
|
2009-12-15 |
2011-07-14 |
Bind Biosciences, Inc. |
Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
|
US20150056300A1
(en)
*
|
2010-10-22 |
2015-02-26 |
Bind Therapeutics, Inc. |
Therapeutic nanoparticles with high molecular weight copolymers
|
US8802240B2
(en)
|
2011-01-06 |
2014-08-12 |
Nanopharmaceuticals Llc |
Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
|
TR201909389T4
(tr)
|
2012-09-17 |
2019-07-22 |
Pfizer |
Terapötik nanopartikülleri hazırlamaya yönelik proses.
|
WO2015074050A1
(en)
|
2013-11-18 |
2015-05-21 |
Nanopharmaceuticals Llc |
Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof
|
MX2016012009A
(es)
|
2014-03-14 |
2016-12-05 |
Pfizer |
Nanoparticulas terapeuticas que comprenden un agente terapeutico, y metodos para su elaboracion y uso.
|
WO2016172712A2
(en)
|
2015-04-23 |
2016-10-27 |
Sydnexis, Inc. |
Ophthalmic composition
|
US9421199B2
(en)
|
2014-06-24 |
2016-08-23 |
Sydnexis, Inc. |
Ophthalmic composition
|
JP6297180B2
(ja)
|
2014-07-03 |
2018-03-20 |
オトノミ—,インク. |
シプロフロキサシン組成物の滅菌
|
CN111700877A
(zh)
|
2014-09-03 |
2020-09-25 |
吉倪塞思公司 |
治疗性纳米粒子和相关的组合物、方法和系统
|
US11382909B2
(en)
|
2014-09-05 |
2022-07-12 |
Sydnexis, Inc. |
Ophthalmic composition
|
WO2016196367A1
(en)
|
2015-05-29 |
2016-12-08 |
Sydnexis, Inc. |
D2o stabilized pharmaceutical formulations
|
AU2016298307A1
(en)
|
2015-07-28 |
2018-02-15 |
Otonomy, Inc. |
TrkB or TrkC agonist compositions and methods for the treatment of OTIC conditions
|
US11246863B2
(en)
|
2015-12-11 |
2022-02-15 |
Alk-Abelló, Inc. |
Ciprofloxacin otic composition and kits and method for using same
|
WO2017214299A1
(en)
|
2016-06-07 |
2017-12-14 |
Nanopharmaceuticals, Llc |
NON-CLEAVABLE POLYMER CONJUGATED WITH αvβ3 INTEGRIN THYROID ANTAGONISTS
|
CN109689027A
(zh)
|
2016-06-29 |
2019-04-26 |
奥德纳米有限公司 |
甘油三酯耳用制剂及其用途
|
US11040004B2
(en)
|
2016-09-16 |
2021-06-22 |
Otonomy, Inc. |
Otic gel formulations for treating otitis externa
|
US11351137B2
(en)
|
2018-04-11 |
2022-06-07 |
Nanopharmaceuticals Llc |
Composition and method for dual targeting in treatment of neuroendocrine tumors
|
US10328043B1
(en)
|
2018-04-11 |
2019-06-25 |
Nanopharmaceuticals, Llc. |
Composition and method for dual targeting in treatment of neuroendocrine tumors
|
CN113164454A
(zh)
|
2018-09-28 |
2021-07-23 |
奥克塞拉有限公司 |
Vap-1的抑制剂
|
US10961204B1
(en)
|
2020-04-29 |
2021-03-30 |
Nanopharmaceuticals Llc |
Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
|
US11723888B2
(en)
|
2021-12-09 |
2023-08-15 |
Nanopharmaceuticals Llc |
Polymer conjugated thyrointegrin antagonists
|